Skip to main content
Premium Trial:

Request an Annual Quote

Chile Looks to Gene Sequencing to Improve Copper Mining

NEW YORK, July 16 – Chile’s state-owned copper miner Codelco has announced plans to launch the Chile Genome Initiative, a project that will use gene sequencing to develop new strains of bacteria that can be used for commercial mining, Dow Jones reported.

Organizers of the initiative have invited private companies to join the “bio-mining” program, which is hoping to raise another $2.5 million from private investors, Dow Jones reported.

Codelco plans to contribute $500,000 to the project over the next three years and other government institutions will invest another $2 million into the research.

Organizers of the initiative said that new bacterial strains could either be applied to unique ore contents or used in the design of new bio-mining technologies.

"Competitive advantage in the mining industry is determined principally by technological innovation," Dow Jones cited Codelco director Juan Villarzu as saying. "The idea is to develop more specific ways of processing copper and if the project is successful, it will have a significant impact on the future development of mining."

The government is hoping to have the program’s administrative team in place within three months, and to auction concessions for various aspects of the research by the end of the year.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.